TAKEDA PHARMACEUTICAL CO LTD 13D and 13G filings for Calithera Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-05-26 07:08 am Sale |
2023-04-17 | 13D | Calithera Biosciences, Inc. CALA |
TAKEDA PHARMACEUTICAL CO LTD | 0 0.000% |
-857,844 (Position Closed) |
Filing |
| 2022-07-06 06:12 am Purchase |
2022-07-01 | 13D | Calithera Biosciences, Inc. CALA |
TAKEDA PHARMACEUTICAL CO LTD | 857,844 15.000% |
116,970 (+15.79%) |
Filing |
| 2022-04-21 06:06 am Purchase |
2021-10-18 | 13D | Calithera Biosciences, Inc. CALA |
TAKEDA PHARMACEUTICAL CO LTD | 740,874 13.200% |
740,874 (New Position) |
Filing |